文献速递免疫规划卫生政策与健康促进传染病防控与疫情报告

南非推进新型结核疫苗引入的国家准备:政策、证据与系统就绪度洞察

Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop.
PubMed 文献 · Vaccine · 2026-05-26

南非结核病负担仍重,多个面向青少年和成人的候选疫苗已进入后期临床开发,新疫苗最早可能于2029年上市。南非国家卫生部与世界卫生组织于2025年7月在约翰内斯堡召开国家结核疫苗准备研讨会,汇聚政策制定者、研究者、监管方、生产商及社区代表,讨论优先人群、交付策略、证据需求与系统准备,强调在交付系统、监管与生产、筹资和公众信任方面协调就绪,并优先追求面向青少年和成人的广泛人群接种策略。

要点

  • 新结核疫苗最早可能2029年上市,需提前开展政策规划与卫生系统准备。
  • 优先追求面向青少年和成人的广泛人群接种,依托现有免疫规划和初级卫生保健平台。
  • 关键行动包括生成南非本土证据、早期接触监管与生产伙伴、加强安全监测数据系统、可持续筹资和社区参与。

核心结论

  • 未来结核疫苗的成功引入取决于交付系统、监管与生产过程、筹资机制和公众信任的协调就绪。

研究设计与样本

  • 南非国家卫生部与世界卫生组织于2025年7月在约翰内斯堡召开国家结核疫苗准备研讨会,汇聚政策制定者、研究者、监管方、生产商及民间社会和社区代表。

主要发现

  • 多个面向青少年和成人的候选疫苗已进入后期临床开发,新结核疫苗最早可能于2029年上市。
  • 研讨会强调追求面向青少年和成人的广泛人群接种策略,并依托现有免疫规划和初级卫生保健平台。
  • 优先事项包括生成南非本土证据、早期接触监管与生产伙伴、加强安全监测和疫苗影响评估的数据系统、可持续筹资及社区参与以建立疫苗信心。

临床怎么用

  • 在疫苗上市前提前规划优先人群和交付策略,并依托现有免疫规划和初级卫生保健平台设计接种服务。
  • 早期与监管机构和生产伙伴沟通,并建立安全监测和疫苗影响评估的数据系统。
  • 通过社区参与建立疫苗信心,并探索可持续筹资方式以支持未来疫苗引入。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tuberculosis (TB) remains a leading cause of morbidity and mortality in South Africa despite substantial progress in diagnosis and treatment. Several candidate vaccines targeting adolescents and adults are now in advanced clinical development, raising the prospect that a new TB vaccine could become available as early as 2029. However, translating clinical trial success into population-level impact will require early policy planning, health system preparedness, and coordinated national action. To support these efforts, the South African National Department of Health and the World Health Organization convened a national TB Vaccine Preparedness Workshop in Johannesburg in July 2025, bringing together policymakers, researchers, regulators, manufacturers, and civil society and community representatives. The workshop aimed to align stakeholders on priority populations and delivery strategies for future TB vaccines, identify evidence needs to inform national policy decision-making, and outline actions required to ensure timely and equitable introduction. Discussions highlighted that successful introduction of a TB vaccine for adolescents and adults will depend on coordinated readiness across delivery systems, regulatory and manufacturing processes, financing mechanisms, and public trust. Participants emphasised pursuing a broad population-level vaccination strategy for adolescents and adults, building on existing immunisation and primary healthcare platforms while adapting delivery strategies to reach these populations. Priorities included generating South Africa-specific evidence to inform policy and financing decisions, engaging early with regulatory authorities and manufacturing partners, strengthening data systems for safety monitoring and evaluation of vaccine impact, developing sustainable financing approaches, and fostering community engagement to build vaccine confidence. These insights provide a foundation for coordinated national planning to ensure timely and equitable introduction of future TB vaccines in South Africa.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Ndjeka N, Subrayen P, Hanekom WA, et al. Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop. Vaccine. 2026. PMID: 42190622. doi:10.1016/j.vaccine.2026.128755

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。